Henan Lingrui Pharmaceutical stock-based incentive, restricted stock repurchase, cancellation implementation announcement.
Henan Lingrui Pharmaceutical: Special legal opinion on the unlocking of the third phase of the 2021 restricted stock incentive plan and the listing of Henan Lingrui Pharmaceutical Co., Ltd.
Henan Lingrui Pharmaceutical: Announcement on the unlocking of the third phase of the 2021 restricted stocks incentive plan and listing by Henan Lingrui Pharmaceutical.
Henan Lingrui Pharmaceutical's Notification on the Expiration of the Third Lock-up Period of Employee Stock Ownership Plan in 2021.
Special legal opinion on the unlocking of the third phase of the 2021 restricted stock incentive plan and the listing of Henan Lingrui Pharmaceutical Co., Ltd.
Announcement on the unlocking of the third phase of the 2021 restricted stocks incentive plan and listing by Henan Lingrui Pharmaceutical.
Announcement of Henan Lingrui Pharmaceutical regarding the partial release of pledged shares by a major shareholder.
Announcement on the achievement of the unlocking conditions of the third phase of Henan Lingrui Pharmaceutical's restricted stock incentive plan for 2021.
Special Legal Opinion on the Achievement of Unlocking Conditions and Repurchase and Cancellation of Restricted Stocks of the Third Restricted Stock Incentive Plan of Henan Lingrui Pharmaceutical Co., Ltd. in 2021
Announcement on Henan Lingrui Pharmaceutical's Intention to Repurchase and Cancel Some Restricted Stocks and Adjust the Repurchase Price.
Announcement of Henan Lingrui Pharmaceutical regarding the repurchase and cancellation of restricted stocks and notification to creditors
Henan Lingrui Pharmaceutical's 2023 annual equity distribution implementation announcement.
Announcement on the results of reducing shareholding by the directors and supervisors of Ling Rui Pharmaceutical
Announcement on the results of the shareholding reduction of shares held by Lingrui Pharmaceutical shareholders
Announcement on Lingrui Pharmaceutical Shareholders' Shareholders' Shareholding Reduction Plan
Ling Rui Pharmaceutical's 2023 Profit Distribution Plan Announcement
Announcement of Ling Rui Pharmaceutical on the cancellation of the pledge of some of the majority shareholders' shares
Lingrui Pharmaceutical's Implementation Notice on Cancellation of Restricted Stock Repurchase Incentives for Certain Equity Incentives
Announcement of the directors and supervisors of Ling Rui Pharmaceutical's plan to reduce shareholding through centralized bidding
Announcement of Ling Rui Pharmaceutical on the cancellation of pledges and pledges of some of the shares of major shareholders and their co-actors
No Data
No Data